Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1

Biochemical and Biophysical Research Communications

Volumn 444, Issue 3, 2014, Pages 346-353

  Liu, Min ^a   Ye, Jiantao ^a   Gao, Si ^a   Fang, Wei ^b   Li, Hong ^a   Geng, Biao ^a   Zou, Jian ^a   Chen, Xi ^a   Chen, Shaorui ^a   Zhang, Luankun ^a   Yue, Zhongbao ^a   Ma, Yunzi ^a   Gao, Hui ^a   Li, Zhuoming ^a   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

AngII; Cardiac hypertrophy; PARP 1; Salvianolic acid B

Indexed keywords

ANGII; CARDIAC HYPERTROPHY; PARP-1; SALVIANOLIC ACID B;

ANGIOTENSIN II; ANIMALS; BENZOFURANS; CARDIOMEGALY; CELLS, CULTURED; MYOCYTES, CARDIAC; NAD; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84894092511     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.045     Document Type: Article

References (35)

1. B.C. Bernardo, K.L. Weeks, L. Pretorius, and J.R. McMullen Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies Pharmacol. Ther. 128 2010 191 227
2. P. Pacher, and C. Szabo Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors Cardiovasc. Drug Rev. 25 2007 235 260
3. J.B. Pillai, M. Gupta, S.B. Rajamohan, R. Lang, J. Raman, and M.P. Gupta Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1545 H1553
4. J.B. Pillai, A. Isbatan, S. Imai, and M.P. Gupta Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity J. Biol. Chem. 280 2005 43121 43130
5. J.B. Pillai, H.M. Russell, J. Raman, V. Jeevanandam, and M.P. Gupta Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure Am. J. Physiol. Heart Circ. Physiol. 288 2005 H486 H496
6. J.C. Ame, C. Spenlehauer, and G. de Murcia The PARP superfamily Bioessays 26 2004 882 893
7. B. Geng, Y. Cai, S. Gao, J. Lu, L. Zhang, J. Zou, M. Liu, S. Yu, J. Ye, and P. Liu PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1 Biochem. Biophys. Res. Commun. 430 2013 944 950
8. W. Ying, P. Garnier, and R.A. Swanson NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes Biochem. Biophys. Res. Commun. 308 2003 809 813
9. M. Javle, and N.J. Curtin The role of PARP in DNA repair and its therapeutic exploitation Br. J. Cancer 105 2011 1114 1122
10. V.B. Pillai, N.R. Sundaresan, G. Kim, M. Gupta, S.B. Rajamohan, J.B. Pillai, S. Samant, P.V. Ravindra, A. Isbatan, and M.P. Gupta Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP- activated kinase pathway J. Biol. Chem. 285 2010 3133 3144
11. L.X. Feng, C.J. Jing, K.L. Tang, L. Tao, Z.W. Cao, W.Y. Wu, S.H. Guan, B.H. Jiang, M. Yang, X.A. Liu, and D.A. Guo Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis Proteomics 11 2011 1473 1485
12. B. Jiang, D. Li, Y. Deng, F. Teng, J. Chen, S. Xue, X. Kong, C. Luo, X. Shen, H. Jiang, F. Xu, W. Yang, J. Yin, Y. Wang, H. Chen, W. Wu, X. Liu, and D.A. Guo Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats PLoS One 8 2013 e59621
13. H. Fan, L. Yang, F. Fu, H. Xu, Q. Meng, H. Zhu, L. Teng, M. Yang, L. Zhang, Z. Zhang, and K. Liu Cardioprotective effects of salvianolic acid a on myocardial ischemia-reperfusion injury in vivo and in vitro Evid. Based Complement. Altern. Med. 2012 2012 508938
14. H. Pan, D. Li, F. Fang, D. Chen, L. Qi, R. Zhang, T. Xu, and H. Sun Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury J. Cardiovasc. Pharmacol. 58 2011 535 542
15. C.S. Du, R.F. Yang, S.W. Song, Y.P. Wang, J.H. Kang, R. Zhang, D.F. Su, and X. Xie Magnesium lithospermate B protects cardiomyocytes from ischemic injury via inhibition of TAB1-p38 apoptosis signaling Front. Pharmacol. 1 2010 111
16. J. Fu, J. Gao, R. Pi, and P. Liu An optimized protocol for culture of cardiomyocyte from neonatal rat Cytotechnology 49 2005 109 116
17. I. Geistrikh, L. Visochek, R. Klein, L. Miller, L. Mittelman, A. Shainberg, and M. Cohen-Armon Ca2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes Biochem. J. 438 2011 337 347
18. J. Gao, G. Yang, R. Pi, R. Li, P. Wang, H. Zhang, K. Le, S. Chen, and P. Liu Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis Transl. Res. 151 2008 79 87
19. K.S. Putt, and P.J. Hergenrother An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors Anal. Biochem. 326 2004 78 86
20. T. Lin, and M.S. Yang Benzo[a]pyrene-induced necrosis in the HepG(2) cells via PARP-1 activation and NAD(+) depletion Toxicology 245 2008 147 153
21. Y. Cai, S.S. Yu, S.R. Chen, R.B. Pi, S. Gao, H. Li, J.T. Ye, and P.Q. Liu Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6 FEBS Lett. 586 2012 866 874
22. I.A. Sergeeva, and V.M. Christoffels Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease Biochim. Biophys. Acta 1832 2013 2403 2413
23. J.H. Ho, and C.Y. Hong Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection J. Biomed. Sci. 18 2011 30
24. K.C. Wollert, and H. Drexler The renin-angiotensin system and experimental heart failure Cardiovasc. Res. 43 1999 838 849
25. C. Pan, L. Lou, Y. Huo, G. Singh, M. Chen, D. Zhang, A. Wu, M. Zhao, S. Wang, and J. Li Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways Ther. Adv. Cardiovasc. Dis. 5 2011 99 111
26. P. Jagtap, and C. Szabo Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors Nat. Rev. Drug Discov. 4 2005 421 440
27. H. Massudi, R. Grant, G.J. Guillemin, and N. Braidy NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns Redox Rep. 17 2012 28 46
28. M. Wang, G.B. Sun, X. Sun, H.W. Wang, X.B. Meng, M. Qin, J. Sun, Y. Luo, and X.B. Sun Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway Toxicol. Lett. 216 2013 100 107
29. Y. Maejima, J. Kuroda, S. Matsushima, T. Ago, and J. Sadoshima Regulation of myocardial growth and death by NADPH oxidase J. Mol. Cell. Cardiol. 50 2011 408 416
30. Y. Zhang, C.G. Tocchetti, T. Krieg, and A.L. Moens Oxidative and nitrosative stress in the maintenance of myocardial function Free Radic. Biol. Med. 53 2012 1531 1540
31. A. Manea, L.I. Tanase, M. Raicu, and M. Simionescu Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells Biochem. Biophys. Res. Commun. 396 2010 901 907
32. Z. Zhou, Y. Liu, A.D. Miao, and S.Q. Wang Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells J. Cell. Biochem. 96 2005 109 116
33. Y.H. Chen, S.J. Lin, H.H. Ku, M.S. Shiao, F.Y. Lin, J.W. Chen, and Y.L. Chen Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells J. Cell. Biochem. 82 2001 512 521
34. P. Wang, F. Tang, R. Li, H. Zhang, S. Chen, P. Liu, and H. Huang Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan Pharmacol. Res. 55 2007 408 417
35. S.Y. Zeng, X. Chen, S.R. Chen, Q. Li, Y.H. Wang, J. Zou, W.W. Cao, J.N. Luo, H. Gao, and P.Q. Liu Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression Can. J. Cardiol. 29 2013 1310 1319